Article info

Download PDFPDF

Short report
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France

Authors

  1. Correspondence to Dr Maxime Dougados; maxime.dougados{at}aphp.fr
View Full Text

Citation

Dougados M, Lucas J, Desfleurs E, et al
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France

Publication history

  • Received November 13, 2021
  • Accepted February 3, 2022
  • First published March 17, 2022.
Online issue publication 
March 17, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.